Press Room


Sign up for the Chicago Marathon’s Team EFGC!
Published on June 23, 2011

The Epilepsy Foundation of Greater Chicago is grateful to be an official Contributing Charity of the 2011 Bank of America Chicago Marathon.  With 1.5 million spectators, 45,000 runners from all 50 states and more than 100 countries – this is one of the premier marathons in the world…and it’s right here in our own backyard on […]

Take Action — Prevent Medicaid Cuts!
Published on June 14, 2011

Medicaid is important to the epilepsy community—but its future is under attack. The Epilepsy Foundation of Greater Chicago urges you to join advocates nationwide for Medicaid call-in days on Tuesday, June 14, Wednesday, June 15, and Thursday, June 16. Across the nation, advocates will urge members of Congress to preserve the Medicaid program. You can join this effort and […]

Epilepsy Awareness Resolution Introduced in U.S. House
Published on June 9, 2011

The Epilepsy Foundation of Greater Chicago is grateful for the bi-partisan leadership and support of Representatives Jo Ann Emerson (R-MO), Ed Perlmutter (D-CO) and Dan Benishek (R-MI) for introducing epilepsy awareness resolution, H.Res. 298.  This resolution shows congressional support for coordinated epilepsy awareness programs. The Foundation has drafted a bill, the RAISE Act (Raising Awareness and Insight […]

Epilepsy 5K Passes $200,000 Mark…and Keeps Growing
Published on May 21, 2011

Walkers, runners, and supporters of all ages have raised over $200,000 for the Epilepsy Foundation of Greater Chicago through the Foundation’s 11th annual Greater Chicago Epilepsy 5K, which took place on Saturday, May 21 at Chicago’s Montrose Harbor. In addition to the May 21 event, a separate 5K event was held the previous weekend, on […]

Drug Shortage Alert: Pfizer Announces DILANTIN® 30 mg Shortage
Published on May 20, 2011

The Epilepsy Foundation has learned that Pfizer is contacting health care professionals, including pharmacists, about a shortage of DILANTIN 30 mg. According to Pfizer, this product shortage is due to a manufacturing issue and not the result of any performance or safety concerns. The company expects DILANTIN 30 mg to be available to patients by June […]